Dharti Proteins: BSE Approves Trading for 5 Lakh Equity Shares

Dharti Proteins Ltd has received trading approval from BSE Limited for 5,00,000 equity shares of Rs. 10/- each. These shares have been allotted on a preferential basis to Successful Resolution Applicants (SRA), their promoter group, and Secured Financial Creditors, as well as to existing public shareholders through a reduction of share capital, in line with the Resolution Plan approved by the Hon'ble NCLT, Ahmedabad Bench. The shares will commence trading on BSE from Thursday, October 08, 2026. This approval signifies a crucial step in the company's restructuring and return to public trading.